1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNIH Quantum Funding Opportunities (various program announcements) is sponsored by National Institutes of Health (NIH). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
U.S. Department of Health & Human Services National Institutes of Health Multiple NIH institutes and centers have released program announcements related to the development of quantum-enabled technologies. These announcements include opportunities for small business funding, as well as research and training grants.
Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STTR) – This notice intends to support small businesses in developing and commercializing quantum technologies for biomedical applications.
Submission of Phase I, Fast-Track, and Direct to Phase II SBIR, as well as Phase I and Fast-Track STTR grant applications from Small Business Concerns, are encouraged for the purpose of developing tools, resources and approaches for commercialization that harness new quantum sensing approaches to solve biomedical research questions. Application areas of interest include preventing, monitoring and diagnosing disease.
The overarching goal is to transition quantum mechanics–based sensing applications from the lab to the biomedical market and clinic. Participating institutes and centers include NEI, NHLBI, NIBIB, NCATS and NCI.
Research and Training Grants Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications – This notice’s intent is to support innovative and potentially transformative research projects in quantum technology applications in biomedical disciplines. Quantum sensing harnesses the power of quantum physics and mechanics to measure quantum states at the subatomic level to improve sensing performance.
The atomic length scale of quantum sensors and their coherence properties, which enable unprecedented spatial resolution and sensitivity, are gaining importance in near-term and real-world applications in biomedical research. Many of the emerging quantum sensing technologies have yet to be explored in biomedical use cases.
Through further technology development and optimization, these novel sensing technologies could drastically enhance current biological imaging and sensing measurements. This offers unique opportunities and the capacity to advance biomedical research and clinical translation. Participating institutes and centers include NIBIB, NEI, NHLBI, NIGMS, NCATS and NCI.
Notice of Announcement of NIH Quantum Technology Prize Competitions – NCATS is leading a set of prize challenges to foster innovation in the fields of quantum computing and quantum sensing as they apply to the biomedical sciences. Partnering institutes and centers include ODSS, CIT, NEI and NIBIB.
NIH Quantum Computing Challenge – This challenge aims to identify novel biomedical use cases that are amenable to quantum computing–based solutions, including quantum-classical hybrid solutions. By combining expertise and advancements made across such disciplines as engineering, material sciences, biomedical sciences and computational sciences, we hope to uncover new crosscutting technologies in this field.
The areas of interest for the current Quantum Computing Challenge include: Quantum algorithms for drug discovery Quantum algorithms for clinical risk predictions, diagnosis and therapeutics Quantum algorithms for biomedical imaging and genomic data analysis NIH Quantum Sensing Technology Challenge – This challenge aims to address key subject areas by incentivizing multidisciplinary teams (biomedical, quantum scientists, engineers, computational experts) to work together to apply emerging quantum-enabled sensing approaches to biomedical research and clinical applications to broaden current capabilities in areas such as early detection, diagnostics and therapeutic development.
The areas of interest for the Quantum Sensing Technology Challenge include: Quantum-enabled approaches to advance biomedical applications Quantum-enabled approaches for early detection and diagnostics Quantum-enabled sensing and imaging devices for diagnostics and monitoring Quantum Computing Innovation Lab NIH Quantum Computing: New Frontiers in Biomedical Research Innovation Lab – An innovation lab is an immersive, interactive experience.
If selected, you will join a highly interdisciplinary group selected, in part, based on a low likelihood of prior interaction in a process designed to catalyze creative thinking. Last updated on November 19, 2024
According to the current listing, eligibility includes: Varies by program announcement; includes small U. S. -based businesses and multidisciplinary teams with expertise in quantum science, biomedicine, and engineering. Confirm the full requirements in the official notice before applying.
The current listing shows varies (SBIR/STTR up to $323,090 for Phase I, $2,153,927 for Phase II). Verify award ceilings, matching requirements, and allowable costs in the official notice.
NIH Quantum Funding Opportunities (various program announcements) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article